astrazeneca

The university can only enroll several hundred people in a clinical trial, given its timeframe, so it is picking volunteers who are at high risk of severe symptoms and infection.

More than 200 dentists and dental students in Oregon have completed the training course offered by the Oregon Health & Science University’s School of Dentistry, with 60 others expected to finish by the end of December.

The institution seeks volunteers for a promising vaccine developed by Oxford University in Britain in collaboration with AstraZeneca, a British pharmaceutical company.